Högskolan i Skövde

his.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • apa-cv
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Inhibition of TrxR1 induces SecTRAPs which promote cytotoxicity and reduce migration in KRAS-driven Lung Cancer
University of Skövde, School of Health Sciences.
2020 (English)Independent thesis Basic level (degree of Bachelor), 20 credits / 30 HE creditsStudent thesis
Abstract [en]

To thrive and proliferate, cancer cells must counteract the oxidative stress, which is upregulated in their environment. To achieve this, antioxidants must be obtained, or their synthesis upregulated. One antioxidant system that is commonly upregulated by cancer cells is the thioredoxin system. Proteins within this system often contain selenium. Two of these, thioredoxin-1 (TRX1) and thioredoxin reductase-1 (TrxR1), are integral in the regulation of ROS. The inhibition of TrxR1 by electrophilic compounds results in selenium compromised thioredoxin reductase derived apoptotic proteins, otherwise known as SecTRAPs. The propagation of these SecTRAPs disrupts the redox balance in the cells resulting in cytotoxic effects, including generation of ROS, membrane instability and cell death. As such, their generation inhibits cell growth and could potentially be therapeutically exploited in future anti-cancer treatments. This study assesses how selenium pre-treatment of lung cancer cells enhances the effect of TrxR1 inhibitors (TRI) such as TRI-1 and auranofin, among others. It measures the effect of inhibition by analysing cell viability, proliferation, and migration. Results indicate that selenium pre-treatment increases the effects of TRI-1 on both migration and proliferation of lung cancer cells. Viability assays indicate 2.5μM as a sub-lethal dose of TRI-1 and auranofin. Effects of TRI-1 at this concentration were used to analyse cytotoxic effects. Migration was reduced in cells with up-regulated TrxR1 synthesis but increased in cells with basal concentrations, while proliferation was decreased by TRI-1 in all cell lines and pre-treatment conditions. Optimization of western blot protocols was also completed for future protein expression analysis.

Place, publisher, year, edition, pages
2020. , p. 47
National Category
Biomedical Laboratory Science/Technology
Identifiers
URN: urn:nbn:se:his:diva-18683OAI: oai:DiVA.org:his-18683DiVA, id: diva2:1449319
External cooperation
Sayin Group, Sahlgrenska Center for Cancer Research
Subject / course
Biomedicine/Medical Science
Educational program
Biomedicine - Study Programme
Supervisors
Examiners
Available from: 2020-06-30 Created: 2020-06-30 Last updated: 2020-06-30Bibliographically approved

Open Access in DiVA

No full text in DiVA

By organisation
School of Health Sciences
Biomedical Laboratory Science/Technology

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 294 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • apa-cv
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf